April 23, 2002; 58 (8 suppl 4) Articles
Considerations in the treatment of relapsing-remitting multiple sclerosis
Peter A. Calabresi
First published April 23, 2002, DOI: https://doi.org/10.1212/WNL.58.8_suppl_4.S10
Considerations in the treatment of relapsing-remitting multiple sclerosis
Peter A. Calabresi
Neurology Apr 2002, 58 (8 suppl 4) S10-S22; DOI: 10.1212/WNL.58.8_suppl_4.S10
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 58 no. 8 suppl 4 S10-S22
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published April 23, 2002.
Copyright & Usage:
© 2002
Author Disclosures
- Peter A. Calabresi, MD
- Peter A. Calabresi, MD
- Address correspondence and reprint requests to Dr. Peter A. Calabresi, Department of Neurology, University of Maryland Medical System, 22 S. Greene St., Baltimore, MD 21201.
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- Interferons: Overview.
- Interferons: Efficacy.
- Interferons: Side-effects profile.
- Glatiramer acetate: Overview.
- Glatiramer acetate: Side-effects profile.
- When to initiate therapy.
- Patient education issues.
- Compliance and discontinuation.
- Switching therapies.
- Management of relapses with glucocorticoids.Acute therapy.
- Other therapies.
- Emerging therapies.
- Summary.
- Footnotes
- References
- Figures & Data
- Info & Disclosures
Advertisement
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.